Society of Nuclear Medicine

SHERPA: Unknown

People

  1. Humm
    Humm
  2. Zanzonico
    Zanzonico
  3. Schoder
    Schoder
  4. Lewis
    Lewis
  5. Pandit-Taskar
    Pandit-Taskar
  6. O'Donoghue
    O'Donoghue
  7. Blasberg
    Blasberg
  8. Morris
    Morris
  9. Scheinberg
    Scheinberg
  10. Beattie
    Beattie

Groups

  1. Radiology, Department of (690)
  2. Molecular Imaging and Therapy Service (567)
  3. GSK Faculty (473)
  4. Sloan Kettering Institute Faculty (386)
  5. Molecular Pharmacology and Chemistry Program Faculty (381)
  6. Medical Physics (292)
  7. Sloan Kettering Institute Postdocs (260)
  8. Department of Medicine (213)
  9. Radiochemistry and Imaging Sciences Service (206)
  10. Center for Molecular Imaging and Biotechnology (139)
Search Within
Formats
  1. Journal Article (458)
  2. Meeting Abstract (410)
  3. Review (32)
  4. Editorial (25)
  5. Miscellaneous (6)
  6. Correspondence (5)
  7. Guidelines (3)
  8. Conference Paper (2)
  9. Research Letter (1)
Groups
  1. Radiology, Department of (690)
  2. Molecular Imaging and Therapy Service (567)
  3. GSK Faculty (473)
  4. Sloan Kettering Institute Faculty (386)
  5. Molecular Pharmacology and Chemistry Program Faculty (381)
  6. Medical Physics (292)

More Groups

People
  1. Steven Larson (294)
  2. John Humm (113)
  3. Ronald Finn (99)
  4. Pat Zanzonico (95)
  5. Heiko Schoder (94)
  6. Jason Lewis (86)

More People

Years
  1. 2025 (8)
  2. 2024 (51)
  3. 2023 (54)
  4. 2022 (24)
  5. 2021 (38)
  6. 2020 (47)

More Years

Publications
  1. Journal of Nuclear Medicine (942)

Results (942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IL13Rα2-targeting antibodies for immuno-PET in solid malignancies
    Journal Article

    Gajecki, L.; Lebedeva, I. V.; Liao, Y. R.; Ambriz, D.; Carter, L. M.; Kumpf, M.; Lovibond, S.; Hachey, J. S.; Graham, M. S.; Postow, M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Computational nuclear oncology toward precision radiopharmaceutical therapies: Current tools, techniques, and uncharted territories
    Review

    Yusufaly, T.; Roncali, E.; Brosch-Lenz, J.; Uribe, C.; Jha, A. K.; Currie, G.; Dutta, J.; El-Fakhri, G.; McMeekin, H.; Pandit-Taskar, N.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Dosimetry of [(177)Lu]Lu-DOTATATE in patients with advanced midgut neuroendocrine tumors: Results from a substudy of the phase III NETTER-1 trial
    Journal Article

    Bodei, L.; Cremonesi, M.; Ferrari, M.; Mittra, E. S.; Kulkarni, H. R.; Deroose, C. M.; Srirajaskanthan, R.; Ramage, J.; Grana, C. M.; Botta, F.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • CD38-targeted 89Zr-DFO-daratumumab PET of myeloma: Immuno-PET impacting clinical care
    Editorial

    Ulaner, G. A.; Lewis, J.; Landgren, O.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • MIRD pamphlet no. 32: A MIRD recovery coefficient model for resolution characterization and shape-specific partial-volume correction
    Journal Article

    Marquis, H.; Schmidtlein, C. R.; de Nijs, R.; Gabiña, P. M.; Gustafsson, J.; Kayal, G.; Ocampo Ramos, J. C.; Carter, L. M.; Bailey, D. L.; Kesner, A. L.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually)
    Editorial

    Czernin, J.; Bodei, L.; Modlin, I.; Calais, J.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Diuresis during (18)F-flotufolastat (rhPSMA-7.3) PET/CT improves recurrence detection after prostatectomy: A prospective phase II trial
    Journal Article

    Lawal, I. O.; Mushtaq, A.; Jani, A. B.; Rupji, M.; Dhere, V. R.; Patel, S. A.; Bilen, M. A.; Patel, P. R.; Sebastian, N. T.; Switchenko, J. M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Dosimetry software for theranostic applications: Current capabilities and future prospects
    Review

    Kesner, A. L.; Brosch-Lenz, J.; Gear, J.; Lassmann, M.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Survival outcomes and dosimetric analysis of Iomab-B (131I-apamistamab) followed by allogeneic hematopoietic cell transplant for patients with TP53 mutated relapsed/refractory AML
    Meeting Abstract

    Natwa, M.; Leung, E.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Wahl, R.; Avril, N.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors
    Meeting Abstract

    Juneau, D.; Kavan, P.; Metser, U.; Abikhzer, G.; Bodei, L.; Liberman, M.; Taunk, N.; O'Reilly, E. M.; Ma, J. S.; Cioci, R.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save

    • Society of Nuclear Medicine – authorized name for: